Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 251681 - 251700 out of 498644 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Greece | (L01FG01) bevacizumab | VEGZELMA C/S.SOL.IN 25MG/ML BT X 1 VIAL X 4ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
Greece | (L01FG01) bevacizumab | ZIRABEV C/S.SOL.IN 25MG/ML BT x 1 VIALx16 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PFIZEREUROPEMAEEIG,BELGIUM |
Greece | (L01FG01) bevacizumab | ZIRABEV C/S.SOL.IN 25MG/ML BT x 1 VIALx4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PFIZEREUROPEMAEEIG,BELGIUM |
Greece | (L01FG02) ramucirumab | CYRAMZA C/S.SOL.IN 10MG/ML BTx2 VIAL x10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | ELILILLYNEDERLANDB.V.,THENEDERLANDS |
Greece | (L01FX02) gemtuzumab ozogamicin | MYLOTARG PD.C.S.INF 5MG/VIAL BTx1 Vial | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | PFIZEREUROPEMAEEIG,BELGIUM |
Greece | (L01FX12) tafasitamab | MINJUVI PD.C.S.INF 200MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | INCYTEBIOSCIENCESDISTRIBUTIONB.V.,THENETHERLANDS |
Greece | (L01FX13) enfortumab vedotin | PADCEV PD.C.S.INF 20MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | ASTELLASPHARMAEUROPEB.V.,LEIDEN,NETHERLANDS |
Greece | (L01FX13) enfortumab vedotin | PADCEV PD.C.S.INF 30MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | ASTELLASPHARMAEUROPEB.V.,LEIDEN,NETHERLANDS |
Greece | (L01FX14) polatuzumab vedotin | POLIVY PD.C.S.INF 140MG/VIAL BT x 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | ROCHEREGISTRATIONGMBH,GERMANY |
Greece | (L01FX14) polatuzumab vedotin | POLIVY PD.C.S.INF 30MG/VIAL BT x 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | ROCHEREGISTRATIONGMBH,GERMANY |
Greece | (L01FX17) sacituzumab govitecan | TRODELVY® PD.C.S.INF 200MG/VIAL BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GILEADSCIENCESIRELANDUC,CO.CORK,IRELAND |
Greece | (L01FX20) tremelimumab | IMJUDO C/S.SOL.IN 20MG/ML BT X 1 VIAL X 15ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
Greece | (L01FX22) loncastuximab tesirine | ZYNLONTA PD.C.S.INF 10MG/VIAL BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell | SWEDISHORPHANBIOVITRUMAB(PUBL),STOCKHOLM,SWEDEN |
Greece | (L01FX24) teclistamab | TECVAYLI INJ.SOL 10MG/ML VIAL BT X 1 VIAL X 3 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
Greece | (L01FX24) teclistamab | TECVAYLI INJ.SOL 90MG/ML VIAL BT X 1 VIAL X 1.7 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
Greece | (L01FX25) mosunetuzumab | LUNSUMIO C/S.SOL.IN 1MG/1ML BT X 1 VIAL X 1 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | ROCHEREGISTRATIONGMBH,GERMANY |
Greece | (L01FX25) mosunetuzumab | LUNSUMIO C/S.SOL.IN 30MG/30ML BT X 1 VIAL X 30 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | ROCHEREGISTRATIONGMBH,GERMANY |
Greece | (L01FX27) epcoritamab | TEPKINLY CS.INJ.SOL 4mg/0,8ml vial (5mg/ml) BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
Greece | (L01FX27) epcoritamab | TEPKINLY INJ.SOL 48mg/0,8ml vial (60mg/ml) BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
Greece | (L01FX28) glofitamab | COLUMVI C/S.SOL.IN 10MG/VIAL BT X 1 VIAL X 10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ROCHEREGISTRATIONGMBH,GERMANY |